Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010

Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010

INTRODUCTION: β-lactam antimicrobials are the most commonly prescribed group of antimicrobials in Canada, and are categorized by the WHO as critically and highly important antimicrobials for human medicine. Because antimicrobial use is commonly associated with the development of antimicrobial resist...

Full description

Bibliographic Details
Main Authors: Shiona K Glass-Kaastra, Rita Finley, Jim Hutchinson, David M Patrick, Karl Weiss, John Conly
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2014/537948
id doaj-1374bd01840b41bca3bdc22649f572c9
record_format Article
spelling doaj-1374bd01840b41bca3bdc22649f572c92021-07-02T05:01:04ZengHindawi LimitedCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322014-01-0125210711210.1155/2014/537948Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010Shiona K Glass-Kaastra0Rita Finley1Jim Hutchinson2David M Patrick3Karl Weiss4John Conly5Public Health Agency of Canada, Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Guelph, Ontario, CanadaPublic Health Agency of Canada, Centre for Food-borne, Environmental and Zoonotic Infectious Diseases, Guelph, Ontario, CanadaDivision of Medical Microbiology, Island Medical Program, University of British Columbia, Vancouver, British Columbia, CanadaBritish Columbia Centre for Disease Control, University of British Columbia, Vancouver, British Columbia, CanadaDepartment of Infectious Diseases and Microbiology, University of Montreal, Hôpital Maisonneuve-Rosemont, Montreal, CanadaDepartment of Medicine, University of Calgary, Calgary, Alberta, CanadaINTRODUCTION: β-lactam antimicrobials are the most commonly prescribed group of antimicrobials in Canada, and are categorized by the WHO as critically and highly important antimicrobials for human medicine. Because antimicrobial use is commonly associated with the development of antimicrobial resistance, monitoring the volume and patterns of use of these agents is highly important.http://dx.doi.org/10.1155/2014/537948
collection DOAJ
language English
format Article
sources DOAJ
author Shiona K Glass-Kaastra
Rita Finley
Jim Hutchinson
David M Patrick
Karl Weiss
John Conly
spellingShingle Shiona K Glass-Kaastra
Rita Finley
Jim Hutchinson
David M Patrick
Karl Weiss
John Conly
Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010
Canadian Journal of Infectious Diseases and Medical Microbiology
author_facet Shiona K Glass-Kaastra
Rita Finley
Jim Hutchinson
David M Patrick
Karl Weiss
John Conly
author_sort Shiona K Glass-Kaastra
title Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010
title_short Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010
title_full Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010
title_fullStr Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010
title_full_unstemmed Longitudinal surveillance of outpatient β-lactam antimicrobial use in Canada, 1995 to 2010
title_sort longitudinal surveillance of outpatient β-lactam antimicrobial use in canada, 1995 to 2010
publisher Hindawi Limited
series Canadian Journal of Infectious Diseases and Medical Microbiology
issn 1712-9532
publishDate 2014-01-01
description INTRODUCTION: β-lactam antimicrobials are the most commonly prescribed group of antimicrobials in Canada, and are categorized by the WHO as critically and highly important antimicrobials for human medicine. Because antimicrobial use is commonly associated with the development of antimicrobial resistance, monitoring the volume and patterns of use of these agents is highly important.
url http://dx.doi.org/10.1155/2014/537948
work_keys_str_mv AT shionakglasskaastra longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010
AT ritafinley longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010
AT jimhutchinson longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010
AT davidmpatrick longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010
AT karlweiss longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010
AT johnconly longitudinalsurveillanceofoutpatientblactamantimicrobialuseincanada1995to2010
_version_ 1721339181117997056

Similar Items